Cargando…
Inflammation Markers in Multiple Sclerosis: CXCL16 Reflects and May Also Predict Disease Activity
BACKGROUND: Serum markers of inflammation are candidate biomarkers in multiple sclerosis (MS). ω-3 fatty acids are suggested to have anti-inflammatory properties that might be beneficial in MS. We aimed to explore the relationship between serum levels of inflammation markers and MRI activity in pati...
Autores principales: | Holmøy, Trygve, Løken-Amsrud, Kristin Ingeleiv, Bakke, Søren Jacob, Beiske, Antonie G., Bjerve, Kristian S., Hovdal, Harald, Lilleås, Finn, Midgard, Rune, Pedersen, Tom, Šaltytė Benth, Jutrate, Torkildsen, Øivind, Wergeland, Stig, Myhr, Kjell-Morten, Michelsen, Annika E., Aukrust, Pål, Ueland, Thor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3777920/ https://www.ncbi.nlm.nih.gov/pubmed/24069377 http://dx.doi.org/10.1371/journal.pone.0075021 |
Ejemplares similares
-
Alpha-tocopherol and MRI Outcomes in Multiple Sclerosis – Association and Prediction
por: Løken-Amsrud, Kristin I., et al.
Publicado: (2013) -
No association of tobacco use and disease activity in multiple sclerosis
por: Kvistad, Silje, et al.
Publicado: (2016) -
Reply to comment: Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014) -
Month of birth and risk of multiple sclerosis: confounding and adjustments
por: Torkildsen, Øivind, et al.
Publicado: (2014) -
Treatment-resistant immune thrombocytopenic purpura associated with LDN use in a patient with MS
por: Torkildsen, Øivind, et al.
Publicado: (2014)